NO994049D0 - Metode for å fremstille farmasöytiske forbindelser - Google Patents

Metode for å fremstille farmasöytiske forbindelser

Info

Publication number
NO994049D0
NO994049D0 NO994049A NO994049A NO994049D0 NO 994049 D0 NO994049 D0 NO 994049D0 NO 994049 A NO994049 A NO 994049A NO 994049 A NO994049 A NO 994049A NO 994049 D0 NO994049 D0 NO 994049D0
Authority
NO
Norway
Prior art keywords
pharmaceutical compounds
preparing pharmaceutical
preparing
compounds
pharmaceutical
Prior art date
Application number
NO994049A
Other languages
English (en)
Norwegian (no)
Other versions
NO994049L (no
Inventor
David W Hoard
Eric D Moher
Vinod Francis Patel
Original Assignee
Lilly Co Eli
Univ Hawaii
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Univ Hawaii, Univ Wayne State filed Critical Lilly Co Eli
Publication of NO994049L publication Critical patent/NO994049L/no
Publication of NO994049D0 publication Critical patent/NO994049D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
NO994049A 1997-02-26 1999-08-23 Metode for å fremstille farmasöytiske forbindelser NO994049D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3911497P 1997-02-26 1997-02-26
US3911697P 1997-02-26 1997-02-26
PCT/US1998/003655 WO1998038158A1 (fr) 1997-02-26 1998-02-25 Procede pour la preparation de composes pharmaceutiques

Publications (2)

Publication Number Publication Date
NO994049L NO994049L (no) 1999-08-23
NO994049D0 true NO994049D0 (no) 1999-08-23

Family

ID=26715826

Family Applications (2)

Application Number Title Priority Date Filing Date
NO994049A NO994049D0 (no) 1997-02-26 1999-08-23 Metode for å fremstille farmasöytiske forbindelser
NO994083A NO994083L (no) 1997-02-26 1999-08-24 Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO994083A NO994083L (no) 1997-02-26 1999-08-24 Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser

Country Status (17)

Country Link
US (1) US6143909A (fr)
EP (2) EP0861838A3 (fr)
JP (2) JP2002513403A (fr)
KR (2) KR20000075623A (fr)
CN (2) CN1255121A (fr)
AU (2) AU738999B2 (fr)
BR (2) BR9811252A (fr)
CA (2) CA2281108A1 (fr)
CZ (1) CZ9902998A3 (fr)
EA (2) EA002547B1 (fr)
ID (2) ID22984A (fr)
IL (2) IL131162A0 (fr)
NO (2) NO994049D0 (fr)
NZ (1) NZ336918A (fr)
PL (2) PL335478A1 (fr)
TR (2) TR199902064T2 (fr)
WO (2) WO1998038158A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4233997A (en) * 1996-08-30 1998-03-19 Eli Lilly And Company Process for preparing pharmaceutical compounds
WO1998009974A1 (fr) * 1996-09-06 1998-03-12 Eli Lilly And Company Procede et nouveaux intermediaires
JP2002527509A (ja) * 1998-10-16 2002-08-27 イーライ・リリー・アンド・カンパニー 抗腫瘍剤を製造するための立体選択的な方法
WO2000034252A2 (fr) * 1998-12-07 2000-06-15 Eli Lilly And Company Procede de crotylboration permettant de produire des composes de cryptophycine
WO2000034253A2 (fr) * 1998-12-07 2000-06-15 Eli Lilly And Company Procede de crotylboration permettant de produire des antineoplasiques et des antifongiques
JP4776843B2 (ja) 1999-10-01 2011-09-21 イムノゲン インコーポレーティッド 免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法
US7229814B2 (en) * 2004-05-05 2007-06-12 Regents Of The University Of Minnesota Nucleic acids and polypeptides involved in the production of cryptophycin
CN101962323B (zh) * 2010-07-16 2013-06-05 中国人民解放军第二军医大学 2-丙烯酰x基-3-取代苯基丙酸类化合物及其用途
CN111333560B (zh) * 2020-04-13 2024-01-23 合肥工业大学 一种制备螺环β-内酰胺的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946835A (en) * 1988-07-15 1990-08-07 Merck & Co., Inc. Antifungal fermentation product and method
US4868208A (en) * 1988-07-15 1989-09-19 Merck & Co., Inc. Antifungal agent and method
US4845086A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845085A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
DE69020143T2 (de) * 1989-02-17 1996-01-25 Chiron Mimotopes Pty Ltd Verfahren zur verwendung und herstellung von peptiden.
US5256802A (en) * 1990-04-03 1993-10-26 Miles Inc. Process for the production of oxiranes
NZ257077A (en) * 1992-11-06 1997-05-26 Chiron Mimotopes Pty Ltd Support for synthesis of modular polymers
GB2282384B8 (en) * 1993-08-18 1997-09-04 Europ Economic Community Drug delivery agents incorporating mitomycin
US5952298A (en) * 1993-12-21 1999-09-14 The University Of Hawaii Cryptophycins
ATE203016T1 (de) * 1993-12-21 2001-07-15 Univ Hawaii Cryptophycine
EP0785941B1 (fr) * 1994-10-14 2000-04-19 Stratagene Marquage de polynucleotides par porphyrines
DE69633667T2 (de) * 1995-03-07 2006-03-02 University Of Hawaii, Honolulu Neue synthetische cryptophycine
AU716620B2 (en) * 1995-03-31 2000-03-02 Nippon Chemiphar Co. Ltd. Epoxysuccinic acid derivatives
US5700826A (en) * 1995-06-07 1997-12-23 Ontogen Corporation 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance
EP0850057A4 (fr) * 1995-08-30 2001-04-11 Lilly Co Eli Composes pharmaceutiques
DE69626544T2 (de) * 1995-12-22 2004-01-15 Lilly Co Eli Arzneistoffe
CN1105496C (zh) * 1996-02-07 2003-04-16 巴科曼实验室国际公司 含一种紫罗烯聚合物及十二烷胺盐的协同抗微生物组合物及其使用方法
ATE201018T1 (de) * 1996-02-27 2001-05-15 Lilly Co Eli Cryptophycinderivate und ihre verwendung als antimikrotubuli mittel
WO1998008505A1 (fr) * 1996-08-30 1998-03-05 Eli Lilly And Company Composes pharmaceutiques
EP0957912A1 (fr) * 1996-08-30 1999-11-24 Eli Lilly And Company Composes pharmaceutiques
JP2001500853A (ja) * 1996-08-30 2001-01-23 イーライ・リリー・アンド・カンパニー 医薬化合物
US6025506A (en) * 1997-02-21 2000-02-15 Dsm N.V. Process for preparing an optically active phenylglycidyl acid derivative
TW438787B (en) * 1997-02-27 2001-06-07 Tanabe Seiyaku Co Process for preparing optically active trans-3-substituted glycidic acid ester

Also Published As

Publication number Publication date
EP0861838A2 (fr) 1998-09-02
NO994083D0 (no) 1999-08-24
CN1252788A (zh) 2000-05-10
KR20000075623A (ko) 2000-12-26
WO1998038158A1 (fr) 1998-09-03
AU6667198A (en) 1998-09-18
EA199900772A1 (ru) 2000-04-24
WO1998038164A1 (fr) 1998-09-03
TR199902064T2 (xx) 2001-10-22
NO994049L (no) 1999-08-23
CA2281104A1 (fr) 1998-09-03
CN1255121A (zh) 2000-05-31
NO994083L (no) 1999-10-25
CA2281108A1 (fr) 1998-09-03
IL131162A0 (en) 2001-01-28
ID22984A (id) 1999-12-23
CZ9902998A3 (cs) 2002-10-16
KR20000075671A (ko) 2000-12-26
IL131205A0 (en) 2001-01-28
BR9807265A (pt) 2000-05-23
AU6667298A (en) 1998-09-18
EA199900770A1 (ru) 2000-04-24
JP2002513403A (ja) 2002-05-08
ID24527A (id) 2000-07-20
PL335478A1 (en) 2000-04-25
EA002547B1 (ru) 2002-06-27
PL335347A1 (en) 2000-04-25
BR9811252A (pt) 2000-09-26
US6143909A (en) 2000-11-07
TR199902065T2 (xx) 2000-02-21
EP0861838A3 (fr) 1998-12-09
EP0861839A1 (fr) 1998-09-02
AU738999B2 (en) 2001-10-04
JP2002512603A (ja) 2002-04-23
NZ336918A (en) 2001-11-30

Similar Documents

Publication Publication Date Title
FI973518L (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
NO994757L (no) Fremgangsmåte for oral administrasjon av proteiner
NO995681D0 (no) Fremgangsmåte for å fremstille fluorbiprofen-tabletter
AR017655A1 (es) Metodo para preparar eteres de monofluormetilo
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
NO20001728D0 (no) Fremgangsmåte for fremstilling av chirale forbindelser
IT1272922B (it) Procedimento per la preparazione di composti metallocenici
ID22840A (id) Proses untuk penyiapan komposisi aspal
NO995851D0 (no) Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
ID24527A (id) Proses pembuatan senyawa-senyawa farmasi
EE9800195A (et) Uudsed analgeetilise toimega ühendid
NO20001777D0 (no) Fremgangsmåte for fremstilling av substituerte 4-fenyl-4- cyanocykloheksankarboksylsyrer
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
FI964410A7 (fi) Menetelmä 4-amino-delta4-3-ketosteroidien valmistamiseksi 4-nitro-delt a4-3-ketosteroidien kautta
ID22430A (id) Proses pembuatan senyawa-senyawa benzotiazolona
NO993863L (no) Forbindelser og fremgangsmÕte for fremstilling av substituerte 4-fenyl-4-cyanocycloheksansyrer
NO965448D0 (no) Farmasöytiske forbindelser
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
FI950307L (fi) Menetelmä bisyklopentadienyyliyhdisteiden valmistamiseksi
EG21226A (en) Process for preparing of new pharmaceutical compound

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application